banner HPMU
TRA CỨU
Thư mục - Vốn tư liệu
Deferiprone therapy improves the oxidative status of LDL in β-thalassemiaHb E patients

Deferiprone therapy improves the oxidative status of LDL in β-thalassemiaHb E patients

 BioExcel Publishing Ltd. 2025
 Eng
Mô tả biểu ghi
ID:33971
NLM B13
Tác giả CN Trần Thị Ngân
Nhan đề Deferiprone therapy improves the oxidative status of LDL in β-thalassemia/Hb E patients
Thông tin xuất bản 2025
Thông tin xuất bản BioExcel Publishing Ltd.
Tóm tắt L1 was shown to prevent the depletion of α-tocopherol, decrease thiobarbituric acid reactive substances and preserve the levels of lipid components in LDL. A negative correlation between serum NTBI and LDL α-tocopherol indicated that the circulating non-redox-active NTBI can lead to the depletion of α-tocopherol. LDL from the washout period showed the highest oxidative susceptibility when evaluated by NBD-Pen.
Thuật ngữ chủ đề Pharmacology
Từ khóa tự do Deferiprone therapy; β-thalassemia/Hb E
Tác giả(bs) CN Pakawit Lerksaipheng
Tác giả(bs) CN Pranee Sutcharitchan
Địa chỉ 100Kho Bài báo quốc tế(1): BQT00055
Tệp tin điện tử https://doi.org/10.7573/dic.2025-7-6
Tệp tin điện tử https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg
MARC
Hiển thị đầy đủ trường & trường con
TagGiá trị
00000000nab#a2200000ui#4500
00133971
00213
0046D8082ED-4439-47E7-913A-883A697D32AE
005202605140929
008081223s2025 vm| vie
0091 0
039[ ] |y 20260514092940 |z phuongntt
041[ ] |a Eng
084[ ] |a B13
100[ ] |a Trần Thị Ngân
245[ ] |a Deferiprone therapy improves the oxidative status of LDL in β-thalassemia/Hb E patients
260[ ] |c 2025
260[ ] |b BioExcel Publishing Ltd.
520[ ] |a L1 was shown to prevent the depletion of α-tocopherol, decrease thiobarbituric acid reactive substances and preserve the levels of lipid components in LDL. A negative correlation between serum NTBI and LDL α-tocopherol indicated that the circulating non-redox-active NTBI can lead to the depletion of α-tocopherol. LDL from the washout period showed the highest oxidative susceptibility when evaluated by NBD-Pen.
650[ ] |a Pharmacology
653[ ] |a Deferiprone therapy
653[ ] |a β-thalassemia/Hb E
700[ ] |a Pakawit Lerksaipheng
700[ ] |a Pranee Sutcharitchan
773[ ] |t Drugs in Context
852[ ] |a 100 |b Kho Bài báo quốc tế |j (1): BQT00055
856[ ] |u https://doi.org/10.7573/dic.2025-7-6
856[1 ] |u https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg
890[ ] |a 1 |b 0 |c 0 |d 0
Dòng Mã vạch Bản sao Nơi lưu Tình trạng Cho phép yêu cầu
1 BQT00055 1 Kho Bài báo quốc tế
#1 BQT00055
Nơi lưu Kho Bài báo quốc tế
Tình trạng
Bình luận